Home / Drug shortages / Ketorolac Tromethamine Injection

Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Gland Pharma Limited

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Gland Pharma Limited with status Current. The shortage was first posted on 06/06/2018. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Gland Pharma Limited
Package NDC
72266-118-25
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)
Initial Posting
06/06/2018
Revised Date

Reason

Demand increase for the drug

FDA data resources